3B Blackbio Dx

Price chart

Previous close

₹1,275.90

Open

₹1,270.00

Day high

₹1,301.50

Day low

₹1,266.00

Listed on NSE since 20 April 2026.

Market value

₹1,095.06 Cr

P/E (trailing)

19.39

EPS (trailing)

₹65.81

Price to book

3.29

Dividend yield

0.39%

Debt to equity

0.01

Profit margin

36.3%

Beta

0.48

Volume today

2,113

Average volume

19,989

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results are unavailable from NSE right now, or none are on file for this company.

The balance sheet is unavailable from NSE right now, or none is on file for this company.

3B Blackbio Dx Limited manufactures and sells molecular diagnostic kits in India. The company designs, develops, manufactures and commercializes qPCR assays, rapid diagnostic tests, NGS-based diagnostic kits, digital PCR assays, and nucleic acid extraction solutions for reliable testing of patient samples, as well as offers oncology and hematology, antimicrobial resistance, infectious diseases, human genetics, extraction, and rapid antigen kits under the TRUPCR, TRUNGS, and TRURAPID brand names; and technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.

Industry

Biotechnology

Based in

Bhopal

Employees

86

Company website · Profile: Yahoo Finance

No headlines name 3B Blackbio Dx in the last day or two.

• Dividend - Rs 5 Per Share

  Dividend · ex-date 22 September 2026

Source: NSE. Latest first.